GERD & the physician-focused 3rd generation of Stretta: Q&A with Dr. Mark Noar

Stretta found to be effective in more GERD patient sub-sets: Q&A with Dr. Mark Noar on his follow-up to 10-year patient data.
Stretta, a non-ablative radiofrequency treatment for gastroesophageal reflux disease, is a safe and effective treatment. Numerous studies have confirmed this, including 10-year patient data released in 2014. Mederi Therapeutics launched RFT3, the third generation of Stretta technology, at Digestive Disease Week 2016 in San Diego.
http://www.beckersasc.com/gastroenterology-and-endoscopy/gerd-the-physician-focused-3rd-generation-of-stretta-q-a-with-dr-mark-noar.html